“Heading into 1Q25, we also believe BPMC could be seen as an attractive target for strategic partnerships, which could boost shares,” JP Morgan writes. With Ayvakit’s launch being a major focus for ...

Searle adds that with an improved balance sheet, inorganic growth opportunities, such as mergers and acquisitions, are also becoming a more viable option. For FY24, the analyst projects earnings of 2 ...